Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

Berlin is knorke: Smart healthcare for patients

28.08.2023
Small computers and robots provide better patient monitoring in hospital and care settings

Read more

Berlin remains on the road to success

21.08.2023
The business development agency Berlin Partner presents its half-yearly balance sheet 2023

Read more

Welcome to Brain City Berlin

10.08.2023
The station "Unter den Linden" brings science into the everyday life of the people of Berlin

Read more

Berlin is knorke: Personalised cancer treatment

31.07.2023
Berlin-based company develops tumour clones to test drugs individually for their effectiveness

Read more

Sustainability at Berlin Partner

26.07.2023
Environmentally friendly solutions for employees in company mobility management

Read more

Berlin is the leading location for 3D printing

19.07.2023
The capital region is one of the most attractive regions for start-ups in additive manufacturing

Read more